Login / Signup
Oncogenic RAS Drives Resistance to Pemigatinib in Cholangiocarcinoma Harboring a FGFR2 Delins Disrupting Ligand Binding.
Mir Lim
Patrick T Lynch
Xiaochen Bai
David Hsiehchen
Published in:
JCO precision oncology (2023)
Keyphrases
</>
wild type
transcription factor